Cath Lab Digest - November 2007 - (Page 39)

Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 2006;355:2395–2407. Dzavik V, Buller CE, Lamas GA, et al. Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: The Total Occlusion Study of Canada (TOSCA)-2 trial. Circulation 2006;114: 2449–2457. Banerjee P, Banerjee T, Khand A, et al. Diastolic heart failure. Neglected or misdiagnosed? J Am Coll Cardiol 2002;39: 138–141. Banerjee P, Clark AL, Nikitin N, Cleland JG. Diastolic heart failure. Paroxysmal or chronic? Eur J Heart Fail 2004;6: 427–443. Parodi G, Carrabba N, Santoro GM, et al. Heart failure and left ventricular remodeling after reperfused acute myocardial infarction in patients with hypertension. Hypertension 2006; 47:706. Henein MY, Priestley K, Davarashvili T, et al. Early changes in left ventricular subendocardial function after successful coronary angioplasty. Br Heart J 1993; 69:501–506. Banerjee P, Norell M. 100 Questions in Cardiology. London, UK: BMJ Publishing, 2001, pp. 68–69. Briguori C, Sarais C, Pagnotta P, et al. Elective versus provisional intra-aortic balloon pump in high-risk percutaneous transluminal coroAm Heart J nary angioplasty. 2003;145:700–707. PTCA guidelines: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001; 37:2215–2238. Kern MJ, Aguirre F, Bach R, et al. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation 1993; 87: 500–511. MacDonald RG, Hill JA, Feldman RL. Failure of intraaortic balloon counterpulsation to augment distal coronary perfusion pressure during percutaneous transluminal coronary angioplasty. Am J Cardiol 1987; 59: 359–361. PTCA guidelines: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001; 37:2215–22138. Kern MJ, Aguirre F, Bach R, et al. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after Circulation coronary angioplasty. 1993;87:500–511. MacDonald RG, Hill JA, Feldman RL. Failure of intraaortic balloon counterpulsation to augment distal coronary perfusion pressure during percutaneous transluminal coronary angioplasty. Am J Cardiol 1987;59:359–361. Stone GW, Webb J, Cox DA, et al. Primary angioplasty in acute myocardial infarction with distal protection of the microcirculation: Principal results from the prospective, randomized EMERALD Trial. J Am Coll Cardiol 2004; 43:285A–286A. Grube E, Schofer JJ, Webb J, et al. Evaluation of a balloon occlusion and aspiration system for protection from distal embolization during stenting in saphenous vein graft. Am J Cardiol 2002;89:941–945. Mizote I, Ueda Y, Ohtani M, et al. Distal protection improved reperfusion and reduced left ventricular dysfunction in patients with acute myocardial infarction who had angioscopically defined ruptured plaque. Circulation 2005;112:1001–1007. Dudek D, Mielecki W, Legutko J, et al. Percutaneous thrombectomy with the RESCUE system in acute myocardial infarction. Kardiol Pol 2004;61:523–533. Lefevre T, Garcia E, Reimers B, et al. X-sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution: Results of the X-sizer in AMI for negligible embolization and optimal ST resolution (X AMINE J Am Coll Cardiol ST) trial. 2005;46:246–252. Birkhead JS, Walker L, Pearson M, et al. Improving care for patients with acute coronary syndromes: Initial results from the National Audit of Myocardial Infarction Heart 2004;90: Project (MINAP). 1004–1009. The European trial of Reduction of cardiac events with Perindopril in stable coronary artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo controlled, multicentre trial (the EUROPA study). Lancet 2003;362: 782–788. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26: 1115–11140. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocarN Engl J Med dial infarction. 2003;348:1309–1321. Pitt B, White H, Nicolan J, et al. Eplerenone reduces mortality 30 days after randomisation following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure. J Am Coll Cardiol 2005; 46:425–431. McNamara RL, Wang Y, Herrin J, et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial J Am Coll Cardiol infarction. 2006;47:2180–2186. De Luca G, van't Hof AWJ, Ottervanger JP, et al. Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty. Eur Heart J 2004;25: 1009–1013. Scognamiglio R, Fasoli G, Nistri S, et al. Left ventricular function and prognosis after myocardial infarction: Rationale for therapeutic strategies. Cardiovasc Drugs Ther 1994;8(Suppl 2):319–325. Becker LC, Silverman KJ, Bulkley BH, et al. Comparison of early thallium-201 scintigraphy and gated blood pool imaging for predicting mortality in patients with acute myocarCirculation 1983; dial infarction. 67:1272–1282. Coronary heart disease: National service framework for coronary heart disease — Modern standards and service models. Chapter 6: Heart failure. Department of Health, United Kingdom, 2000. 14. 9. 19. 23. 15. 24. 10. 16. 20. 11. 25. 12. 21. 17. 26. 13. 22. 18. CLD Volunteer Survey 27. Please complete the questions below and fax to 216-393-0445 or visit www.cathlabdigest.com to complete the survey online. 1. Do you volunteer to help raise awareness regarding heart health in your community? 2. If yes, how do you choose to donate your time regarding community heart health? Yes No 28. 3. Does your hospital have a Heart Walk team? Yes No 29. AHA affiliates all around the U.S. sponsor annual Heart Walks. Walkers can organize teams at the companies where they work or with family and friends. Walkers ask others to support their walk effort by sponsoring them with a donation to the American Heart Association. 4. Does your hospital follow the AHA’s “Get with the Guidelines” format for patient education and discharge planning? (“Get with the Guidelines” is a national program. Numerous studies have shown a reduction of mortality and morbidity the greater the number of guidelines that are implemented and adhered to.) Yes No 5. Prior to this survey, were you aware of the Go Red for Women campaign from the American Heart Association? Yes No 6. If yes, do you participate in the campaign in some way? Yes No 32. 30. 31. 7. Prior to this survey, were you aware of the Start! Walking program from the American Heart Association? Yes No 8. If yes, do you participate in the campaign in some way? Yes No 33. 9. Prior to this survey, were you aware of the Power to End Stroke campaign by the American Stroke Association? Yes No 10. If yes, do you participate in the campaign in some way? 11. Does your hospital plan to become Stroke Certified? Yes Yes No No Yes No 35. 34. 12. Prior to this survey, were you aware of the Alliance for a Healthier Generation? 13. If yes, do you participate in the campaign in some way? Yes No 14. Do you have school-age children who participate in Hoops for Heart or Jump Rope for Heart programs at their school? Yes No 15. If you have volunteered in the fight against heart disease, you are welcome to share thoughts about your experience: Thank you for completing our survey! Cath Lab Digest will publish the results in an upcoming 2007 issue. 36. http://www.cathlabdigest.com http://www.cathlabdigest.com

Table of Contents Feed for the Digital Edition of Cath Lab Digest - November 2007

Henry Ford Heart and Vascular Institute Treating Patients with Complex Vascular Disease with a Multi-Disciplinary Approach Improving Patient Compliance with Antiplatelet Medications Clinical Editor’s Corner Cath Lab Nurse/Tech Vascular Access and Closure Using the StarClose® Device The Clinical and Economic Impact of Measuring Fractional Flow Reserve FFR and Choosing an Optimal Revascularization Strategy Finally! The New Registered Cardiac Electrophysiology Specialist (RCES) Credential Use of a Mobile Lab to ‘Test the Waters’ at a Rural Hospital Remembering a Cardiac Cath Lab History ACVP• Membership Page What Do You Think? The Ten-Minute Interview with… Ernie Livingston, RN, BSN SICP* Chapter Updates Who’s in Charge? Working to Eliminate Bottlenecks: Florida Hospital’s Cardiac Cath Lab Achieves Greater Efficiency and Higher Satisfaction Preserving Left Ventricular Function during Percutaneous Coronary Intervention Ask the Clinical Instructor: A Q&A Column for Those New to the Cath Lab Making the Most of Your First Impression: Interviewing Tips and Techniques CEU Education Center Clinical & Industry News Meetings Calendar

Cath Lab Digest - November 2007

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.